Hookipa Pharma Incis A Clinical Stage Biopharmaceutical Company Based In New Yorkfocused On Developing Immunotherapies For Infectious Diseases And Cancersfounded In 2011The Company Employs 87 Staff And Is Publicly Traded On Nasdaq Under The Ticker Hook The Company Utilizes A Proprietary Arenavirus Platform To Create Viral Vectors That Stimulate Strong Immune Responsesits Pipeline Includes Investigational Therapies Such As Eseba Vec For Hpv16Head And Neck Cancershb 700 For Multi Kras Mutant Targeting In Various Cancersand Candidates For Hepatitis B And Hivhookipa Collaborates With Gilead Sciences And Roche To Enhance Its Research And Development Effortsthe Company Aims To Improve T Cell Mobilization And Address Challenges In Current Immunotherapy Approaches
